FedericoA.MonzonMD

Pathology • Houston, TX

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Monzon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Monzon's full profile

Already have an account?

Office
5008 Crawford St
Houston, TX 77004
Phone+1 713-829-7958

Education & Training

UPMC Medical EducationFellowship, Molecular Genetic Pathology, 2002 - 2003
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Pathology-Anatomic and Clinical, 1998 - 2002
Universidad Nacional Autonoma de MexicoClass of 1992

Certifications & Licensure

AZ State Medical License 2017 - 2026
CA State Medical License 2014 - 2025
TX State Medical License 2008 - 2024
PA State Medical License 2002 - 2018
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Molecular Genetic Pathology

Publications & Presentations

PubMed

6 citations
Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.
Sherri Borman, Jeff Wilkinson, Lauren Meldi-Sholl, Clare Johnson, Kelsey Carter
Diagnostic Pathology. 2022-02-25
21 citations
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction.
Eric D. Whitman, Vadim P. Koshenkov, Brian R. Gastman, Deri Lewis, Eddy C. Hsueh
JCO Precision Oncology. 2021-09-13
11 citations
Sentinel lymph node biopsy in melanoma: beyond histologic factors
Michael J Carr, Federico A. Monzon, Jonathan S. Zager
Clinical & Experimental Metastasis. 2021-06-08

Press Mentions

Castle Biosciences Presents Data on DecisionDxNovember 12th, 2020
Castle Biosciences to Present Data at the American Society of Dermatopathology (ASDP) 57th Virtual Annual MeetingOctober 29th, 2020